List view / Grid view
The Gates Foundation will fund Novartis’ discovery and development of…
The Gates Foundation will fund Novartis’ discovery and development of a gene therapy for sickle cell disease that is accessible for low- and middle-income countries.
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB collaboration)…
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB collaboration) was devised to create transformative regimens for TB treatment, irrespective of drug resistance status.
GSK and BMGF will invest a combined $1.8 million in…
29 October 2013 | By GlaxoSmithKline
GSK and BMGF will invest a combined $1.8 million in early stage research into vaccine thermostability...
Groundbreaking partnership that aims to speed the discovery of essential…
6 July 2012 | By Abbott
Groundbreaking partnership that aims to speed the discovery of essential new treatments...
Alcon to accelerate growth through Novartis strength in market access,…
13 September 2011 | By Novartis
Alcon to accelerate growth through Novartis strength in market access, reimbursement, and research capability...
Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM)…
1 July 2011 | By Novartis
Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder)...
Results from the pivotal Phase III GLOW2 clinical trial show…
30 June 2011 | By Novartis
Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237, 50 mcg significantly improved lung function...
FDA panel voted in favor of the overall efficacy but…
21 June 2011 | By Novartis
FDA panel voted in favor of the overall efficacy but not the overall safety of ACZ885...
An advisory committee recommended that the FDA approve QAB149 (indacaterol)…
9 March 2011 | By Novartis
An advisory committee recommended that the FDA approve QAB149 (indacaterol) in the US...
Patients with COPD treated with Onbrez® Breezhaler® & tiotropium notice…
10 February 2011 | By Novartis
Patients with COPD treated with Onbrez® Breezhaler® & tiotropium notice improvements...
